drugset / Trial / NCT05698758

Intranasal Dexmedetomidine for Adult Patients Undergoing Phacoemulsification Cataract Surgery

NCT05698758 ↗

Unknown 64 enrolled Guangzhou First People's Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The investigators designed this study to examine whether the intranasal dexmedetomidine, as a preoperative drug, could improve the satisfaction of adult patients undergoing phacoemulsification cataract surgery.

Timeline

Start
2023-01-10
Primary completion
2023-03-31
Completion
2023-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextrometropine Unknown 1 ug/kg Intranasal

Indications